ABVC BioPharma, Inc. (ECOC) Operating cash flow 2017–2025
ABVC BioPharma, Inc. (ECOC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.0MFY2025 · since FY2017: -$1.5M → -$3.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.0M | -65.1% |
| FY2024 | -$1.8M | +56.8% |
| FY2023 | -$4.2M | +43.4% |
| FY2022 | -$7.4M | +2.6% |
| FY2021 | -$7.6M | -66.5% |
| FY2020 | -$4.6M | -45.6% |
| FY2019 | -$3.1M | -248.1% |
| FY2018 | -$900,531 | +39.4% |
| FY2017 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ECOC financial trends
ECOC RevenueECOC Net incomeECOC Net marginECOC Gross profitECOC Gross marginECOC Operating incomeECOC Operating marginECOC Free cash flowECOC Capital expendituresECOC Return on equityECOC Stock buybacksECOC Dividends paidECOC Total assetsECOC Total liabilitiesECOC Shareholders’ equityECOC overview →